Although there is much to be further explored, here we demonstrate for the first time that STAT1 might act at both transcriptional and post-transcriptional levels to modulate the PARP1 level in HGSOC, suggesting new pathways to be exploited for targeting cancer cells, based on their dependency on PARP1. This evidence concerns the gene STAT1 and cancer.